Fig. 1.

Schematic diagram of the in vivo experiments. The naïve and model groups received PBS intragastrically for 9 d; the treatment groups received GQP suspension (227.5, 445, or 910 mg/kg) for the last 2 d of the experimental period. Prevention groups received GQP suspension at the same doses for 9 d, whereas the aspirin group was administered aspirin (22.75 mg/kg) for 9 d. Except for the control group, all the other groups were injected with carrageenan solution (100 mg/kg) on day 7. On day 9, all mice were euthanized, and mouse tails were photographed and evaluated for blood flow. Blood, tail, liver, and lung samples were collected for further analyses.